A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Try eating at least one more serving of a fruit or vegetable every day if you are not getting at least five a ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Weight-loss jabs have become so popular that recent figures suggest that over half a million people are taking either ...

A groundbreaking study shows that GLP-1 agonist anti-obesity drugs not only aid weight loss but significantly improve ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...

Why Warren Buffett was selling stocks, Marvell’s outlook fails to wow Wall Street, and more news to start your day.

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people ... Last week, Eli Lilly said it ...